Hyland Therapeutic Div., Travenol Laboratories
Country not established
- Devices
- 44
What Hyland Therapeutic Div., Travenol Laboratories makes
The company produces diagnostic reagents and controls for laboratory testing, including low ionic strength solutions for blood processing, human plasminogen and immunoglobulin tests, and serums for chemistry reference standards. It also offers test kits for detecting herpes antibodies and measuring HDL-apolipoprotein A levels, alongside radioreceptor control reagents for clinical chemistry assays.
These products are regulated under FDA’s Class I and Class II device categories, with most submissions supported by 510(k) clearances. The manufacturer’s portfolio is listed in the FDA’s 510(k) registry, and the company is based in the United States.
Catalogue
Search and filter all 44 devicesFrequently asked questions
How many devices does Hyland Therapeutic Div., Travenol Laboratories have in the registry?
The registry currently lists 44 devices for Hyland Therapeutic Div., Travenol Laboratories. Devices recorded under merged duplicate company entries are counted once.
Which registries list Hyland Therapeutic Div., Travenol Laboratories's devices?
Among its 44 most recently registered devices, Hyland Therapeutic Div., Travenol Laboratories has devices listed in FDA 510(k) (44 devices).
What risk classes do Hyland Therapeutic Div., Travenol Laboratories's devices fall under?
Among its 44 most recently registered devices, the classes recorded for Hyland Therapeutic Div., Travenol Laboratories's devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Hyland Therapeutic Div., Travenol Laboratories in the registry?
The most recently registered devices listed for Hyland Therapeutic Div., Travenol Laboratories include LOW IONIC STRENGTH SOLUTION (LISS), LAS-R HUMAN PLASMINOGEN TEST, Q-PAK CHEMISTRY RADIORECEPTOR CONTROL C and TMA BICARBONATE/GLYCEROL DILUENT.